The Heart Failure community, including professional societies and patient advocacy organizations, have created many resources and tools to support Heart Failure patients and their caregivers. Here, you can find resources collected from the community through the Multi-stakeholder Summit* to help you take control of your journey after being diagnosed with Heart Failure and leaving the…
FARXIGA is the first SGLT2 inhibitor proven to significantly reduce the risk of cardiovascular death and hospitalization for heart failure. AstraZeneca’s FARXIGA® (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction (HFrEF) with and…
First participants dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine. Pfizer and BioNTech ramping up manufacturing capabilities to further increase production capacity in 2020/202. NEW YORK, USA, and MAINZ, Germany, May 5, 2020 – Pfizer Inc. (NYSE:PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have…
The Department of Health and Human Services (HHS) has announced how it will disseminate the remainder of the $100 billion Provider Relief Fund established by the Coronavirus Aid, Relief, and Economic Security (CARES) Act enacted on March 27. HHS has apportioned $50 billion for “general allocation” to Medicare facilities and providers impacted by COVID-19. Distribution will be…
Reports from the front lines of hospitals indicate a marked drop in the number of heart attacks and strokes nationally. But, COVID-19 is definitely not stopping people from having heart attacks, strokes, and cardiac arrests. We fear it is stopping people from going to the hospital and that can be devastating. You might…
The heart health fair raised awareness about the signs, symptoms, and risks associated with heart disease. In the U.S., approximately 43 million women are living with heart disease. “Statistics now show that 1 out of every 4 women will die from cardiovascular disease, with the greatest risk in young women, particularly women of color,” said…